Vice President of Portfolio Generation
Neil is responsible for developing our Therapeutic Innovation’s portfolio of early drug discovery opportunities in close collaboration Cancer Research UK researchers and clinicians as well as our drug discovery teams.
Neil has worked for Cancer Research UK drug discovery for over 14 and is part of the leadership team that has overseen the creation of multiple drug discovery partnerships and delivered 3 recent clinical development programmes. He has also led the scientific negotiation and subsequent deliver of high value drug discovery alliance with commercial partners including AstraZeneca and Celgene/BMS.
A cell biologist by training, Neil has over 20 years of drug discovery experience working at the interface between academic and industry and is a passionate believer that collaborative science is critical to deliver effective therapies to cancer patients.
Prior to joining Cancer Research Horizons, Neil obtained his first degree in Medical Biochemistry from the University of Birmingham, a PhD from the University of Southampton and conducted postdoctoral research at the Institute of Cancer Research.